|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.52 USD | -2.43% |
|
-1.96% | +78.09% |
| 05/03 | Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating | MT |
| 05/03 | US stocks close up on Iran diplomacy hopes; tech leads rebound | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.07TCr | - | ||||
| 7.8TCr | |||||
| 5.54TCr | |||||
| 5.12TCr | |||||
| 4.94TCr | |||||
| 2.71TCr |
- Stock Market
- Equities
- MRNA Stock
- Charts Moderna, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition